Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy

Cancer Letters

Volumn 271, Issue 2, 2008, Pages 342-351

  Casas, Adriana ^a   Venosa, Gabriela Di ^a   Vanzulli, Silvia ^b   Perotti, Christian ^a   Mamome, Leandro ^a   Rodriguez, Lorena ^a   Simian, Marina ^c   Juarranz, Angeles ^d   Pontiggia, Osvaldo ^c   Hasan, Tayyaba ^e   Batlle, Alcira ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c Instituto de Oncologia Angel H Roffo   (Argentina)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adhesion; Aminolevulinic acid; Invasion; Metastasis; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; BETA1 INTEGRIN; MATRIGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PHENOTYPE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMINOLEVULINIC ACID; ANIMALS; CELL ADHESION; DRUG RESISTANCE, NEOPLASM; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PHOTOCHEMOTHERAPY;

MUS;

EID: 53349089311     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.06.023     Document Type: Article

References (66)

1. Dougherty T. Photodynamic therapy (PDT) of malignant tumours. Crit. Rev. Oncol. Hematol. 2 (1984) 83-116
2. Gomer C. Photodynamic Therapy (1987), Pergamon Press, Oxford, England
3. Weishaupt K., Gomer C., and Dougherty T. Identification of singlet oxygen as the cytotoxic agent in photoactivation of a murine tumour. Cancer Res. 36 (1976) 2326-2329
4. Kennedy J., Pottier R., and Pross G. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B 6 (1990) 143-148
5. Fukuda H., Casas A., Chueke F., Paredes S., and Batlle A. Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoural cell killing. Int. J. Biochem. 25 (1993) 1395-1398
6. Babilas P., Landthaler M., and Szeimies R. Photodynamic therapy in dermatology. Eur. J. Dermatol. 16 (2006) 340-348
7. Cairnduff F., Stringer M.R., Hudson E.J., Ash D.V., and Brown S.B. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer 69 (1994) 605-608
8. Fritsch C., and Ruzicka T. Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. J. Environ. Pathol. Toxicol. Oncol. 25 (2006) 425-439
9. Kelty C.J., Brown N.J., Reed M.W., and Ackroyd R. The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis. Photochem. Photobiol. Sci. 1 (2002) 158-168
10. Kurwa H., and Barlow R. The role of photodynamic therapy in dermatology. Clin. Exp. Dermatol. 24 (1999) 143-148
11. Gossner L., Stolte M., Sroka R., Rick K., May A., Hahn E., and Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 114 (1998) 448-455
12. Hautmann H., Pichler J.P., Stepp H., Baumgartner R., Gamarra F., and Huber R.M. In vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue. Respir. Res. 8 (2007) 33
13. Stepp H., Beck T., Pongratz T., Meinel T., Kreth F.W., Tonn J.Ch., and Stummer W. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. J. Environ. Pathol. Toxicol. Oncol. 26 (2007) 157-164
14. Kriegmair M., Baumgartner R., Knuechel R., Stepp H., Hofstadter F., and Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J. Urol. 155 (1996) 105-110
15. Gahlen J., Prosst R.L., Pietschmann M., Haase T., Rheinwald M., Skopp G., Stern J., and Herfarth C. Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies. Ann. Surg. 60 (2002) 235-252
16. Navone N., Polo C., Frisardi A., Andrade N., and Batlle A. Heme biosynthesis in human breast adenocarcinoma. Mimetic in vitro studies and some heme enzymic activity levels. Int. J. Biochem. 22 (1990) 1407-1411
17. Navone N., Polo C., Frisardi A., and Batlle A. Mouse mammary carcinoma PBGase and hydroxymethylbilane synthetase. Comp. Biochem. Physiol. B 98 (1991) 67-71
18. Van Hillesberg R., Van der Berg J., Kort W., Terpstra O., and Wilson J. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology 103 (1992) 647-651
19. Casas A., Perotti C., Ortel B., Di Venosa G., Saccoliti M., Batlle A., and Hasan T. Induction of murine tumour cell lines resistant to ALA-mediated photodynamic therapy. Int. J. Oncol. 29 (2006) 397-405
20. Gomer C., Ferrario A., and Murphree A. The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. Br. J. Cancer 56 (1987) 27-32
21. Schreiber S., Gross S., Brandis A., Harmelin A., Rosenbach A., Belkin V., Scherz A., and Salomon Y. Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery. Int. J. Cancer 99 (2002) 279-285
22. Lisnjak I., Kutsenok V., Polyschuk L., Gorobets O., and Gamaleia N. Effect of photodynamic therapy on tumour angiogenesis and metastasis in mice bearing Lewis lung carcinoma. Exp. Oncol. 27 (2005) 333-335
23. Rousset N., Vonarx V., Eleouet S., Carre J., Kerninon E., Lajat Y., and Patrice T. Effects of photodynamic therapy on adhesion molecules and metastasis. J. Photochem. Photobiol. B 52 (1999) 65-73
24. Momma T., Hamblin M., Wu H., and Hasan T. Photodynamic therapy of orthotopic prostate cancer with benzoderivative: local control and distant metastasis. Cancer Res. 58 (1998) 5425-5431
25. Solban N., Selbo P., Sinha A., Chang S., and Hasan T. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer. Cancer Res. 66 (2006) 5633-5640
26. Kosharskyy B., Solban N., Chang S., Rizvi I., Chang Y., and Hasan T. A mechanism-based combination therapy reduces local tumour growth and metastasis in an orthotopic model of prostate cancer. Cancer Res. 66 (2006) 10953-10958
27. Moor A.C. Signaling pathways in cell death and survival after photodynamic therapy. J. Photochem. Photobiol. B 57 (2000) 1-13
28. Cecic I., and Korbelik M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 183 (2002) 43-51
29. Christofori G. New signals from the invasive front. Nature 441 (2006) 444-450
30. Werbajh S., Urtreger A., Puricelli L., De Lustig E., Bal de Kier Joffe E., and Kornblihtt A. Downregulation of fibronectin transcription in highly metastatic adenocarcinoma cells. FEBS Lett. 440 (1992) 277-281
31. Workman P., Balmain A., and Hickman J. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (Second Edition). Br. J. Cancer 77 (1998) 1-10
32. Albini A., Iwamoto Y., Kleinman H., Martin G., Aaronson S., Kozlowski J., and McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumour cells. Cancer Res. 47 (1987) 3239-3245
33. Ladeda V., Adam A., Puricelli L., and Bal de Kier Joffe E. Apoptotic cell dearth in mammary adenocarcinoma cells is prevented by soluble factors present in the target organ of metastasis. Breast Cancer Res. Treat. 69 (2001) 39-51
34. Lowry O., Rosebrough N., Farr L., and Randall R. Protein measurement with the folin phenol reagents. J. Biol. Chem. 193 (1951) 265-275
35. Liotta L., Steeg P., and Stetler-Stevenson W. Cancer metastasis and angiogenesis: an inbalance of positive and negative regulation. Cell 64 (1991) 327-336
36. Simian M., Molinolo A., and Lanari C. Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression. Am. J. Pathol. 168 (2006) 270-279
37. Karrer S., Bosserhof A., Weiderer P., Landthaler M., and Szeimies R. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J. Invest. Dermatol. 120 (2003) 325-331
38. Au C., Luk S., Jackson C., Ng H., Yow C., and To S. Differential effects of photofrin 5-aminolevulinic acid and calphostin C on glioma cells. J. Photochem. Photobiol. B 85 (2006) 92-101
39. Overhaus M., Heckenkamp J., Kossodo S., Leszcynski D., and LaMuraglia G. Photodynamic therapy generates a matrix barrier to invasive vascular cell migration. Circ. Res. 86 (2000) 334-340
40. Waterman P.R., Overhaus M., Heckenkamp J., Nigri G.R., Fungaloi P.F., Landis M.E., Kossodo S.C., and M LaMuraglia G. Mechanisms of reduced human vascular cell migration after photodynamic therapy. Photochem. Photobiol. 75 (2002) 46-50
41. Eccles S. Targeting key steps in metastatic tumour progression. Curr. Opin. Genet. Dev. 15 (2005) 77-86
42. Jiang F., Chopp M., Katakowski M., Cho K.-K., Yang X., Hochbaum N., Tong L., and Mikkelsen T. Photodynamic therapy with photofrin reduces invasiveness of malignant human glioma cells. Lasers Med. Sci. 17 (2002) 280-288
43. Pauli B., Schwartz D., Thonar E., and Kuettner K. Tumour invasion and host extracellular matrix. Cancer Metastasis Rev. 2 (1983) 129-152
44. Terranova V., Rohrbach D., and Martin G. Role of laminin in the attachment of PAM 212 (epithelial) cells to basement membrane collagen. Cell 22 (1980) 719-726
45. Mohler J.L., Levy F., and Sharief Y. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model. Cancer Res. 51 (1991) 6580-6585
46. Yoshimura M., Nishikawa A., Ihara Y., Taniguchi S., and Taniguchi N N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc. Natl. Acad. Sci. USA 92 (1995) 8754-8758
47. Ek E., Dass C., Contreras K., and Choong P. Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumour activities of pigment epithelium-derived factor. Clin. Exp. Metastasis 24 (2007) 93-106
48. Dumont J., Jones W., and Bitonti A. Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C. Cancer Res. 52 (1992) 1195-1200
49. Lichtner R., Kaufmann A., Kittmann A., Rohdeschulz B., Walter J., Williams L., Ullrich A., Schirrmacher V., and Khazaie K. Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells. Oncogene 10 (1995) 1823-1832
50. r 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res. 52 (1992) 4540-4544
51. Savarese D., Russel J., Fatatis A., and Liotta L. Type IV collagen stimulates an increase in intracellular calcium: potential in tumour cell motility. J. Biol. Chem. 267 (1992) 21928-21935
52. Foultier M., Vonarx V., Cordel S., Combre A., and Patrice T. Modulation of colonic cancer cell adhesiveness by hematoporphyrin derivative photodynamic therapy. J. Photochem. Photobiol. B: Biol 23 (1994) 9-17
53. Vonarx V., Moultier M., de Brito X., Anasagasti L., Morlet L., and Patrice T. Photodynamic therapy decreases cancer colonic cell adhesiveness and metastatic potential. Res. Exp. Med. 195 (1995) 101-116
54. Uzdensky A., Juzeniene A., Kolpakova E., Hjortland G., Juzenas P., and Moan J. Photosensitization with protoporphyrin IX inhibits attachment of cancer cells to a substratum. Biochem. Biophys. Res. Commun. 322 (2004) 452-457
55. 1 integrin expression in ovarian cancer cells. Br. J. Cancer 80 (1999) 946-953
56. Margaron P., Sorrenti L., and Levi J. Photodynamic therapy inhibits cell adhesion without altering integrin expression. Biochim. Biophys. Acta 359 (1997) 200-210
57. Denstman S., Dillehay L., and Williams J. Enhanced susceptibility to HpD-sensitized phototoxicity and correlated resistance to trypsin detachment in SV40 transformed IMR-90 cells. Photochem. Photobiol. 43 (1986) 145-147
58. Ball D., Mayhew S., Vernon D., Griffin M., and Brown S. Decreased efficiency of trypsinization of cells following photodynamic therapy: evaluation of a role for tissue transglutaminase. Photochem. Photobiol. 73 (2001) 47-53
59. Uzdensky A., Juzeniene A., Ma L., and Moan J. Photodynamic inhibition of enzymatic detachment of human cancer cells from a substratum. Biochim. Biophys. Acta 1670 (2004) 1-11
60. Tsai J., Wu C., Chien H., and Chen C. Reorganization of cytoskeleton induced by 5-aminolevulinic acid-mediated photodynamic therapy and its correlation with mitochondrial dysfunction. Lasers Surg. Med. 36 (2005) 398-408
61. Uehara M., Inokuchi T., Tobita T., Ohba S., and Asahina I. Expression of heat shock protein 47 in the fibrous tissue adjacent to mouse tumour subjected to photodynamic therapy. Oral Oncol. 43 (2007) 804-810
62. Fungaloi P., Statius van Eps R., Wu Y.P., Blankensteijn J., de Groot P., van Urk H., van Hillegersberg R., and LaMuraglia G. Platelet adhesion to photodynamic therapy-treated extracellular matrix proteins. Photochem. Photobiol. 75 (2002) 412-417
63. Uhm J., Gladson C., and Rao J. The role of integrins in the malignant phenotype of gliomas. Front. Biosci. 4 (1999) d188-d199
64. Girotti A. Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J. Photochem. Photobiol. B 63 (2001) 103-113
65. Shen H., Spikes J., Kopecekov A., and Kopecek J. Photodynamic crosslinking of proteins. I. Model studies using histidine- and lysine-containing N-(2-hydroxypropyl)methacrylamide copolymers. J. Photochem. Photobiol. B 34 (1996) 203-210
66. Stockert J.C., Juarranz A., Villanueva A., Nonell S., Horobin R., Soltermann A., Durantini E., Rivalona V., Colombo L., Espada J., and Cañete M M. Photodynamic therapy: selective uptake of photosensitizing drugs into tumor cells. Curr. Top. Pharmacol. 8 (2004) 185-217